Annales De Dermatologie Et De Venereologie最新文献_第10页

Clinical profile and quality of life of patients in a hospital setting in Lomé (Togo) 多哥洛美医院患者的临床概况和生活质量。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2024-02-01 DOI: 10.1016/j.annder.2023.103240

A.-S. Akakpo , R. Halidou Sidibe , J.-N. Téclessou , P. Kassang , P. Gnossike , A. Mouhari-Touré , K. Kombaté , P. Pitché , B. Saka

引用次数: 0

Erythematous papule after patch testing. Is all that glitters really gold? 斑贴试验后的红斑丘疹。闪闪发光的真的都是金子吗？

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2024-02-01 DOI: 10.1016/j.annder.2023.103239

J. Gimeno Castillo, A. Onaindia Pérez, A. Saenz Aguirre

引用次数: 0

Encorafenib-induced eccrine squamous syringometaplasia 安柯拉非尼诱发的无阴道鳞状鞘膜增生症。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2024-02-01 DOI: 10.1016/j.annder.2023.103241

A. Potereau, M. Carmi, F. Luquet-Plantier, V. Gras, A. Id Baih, A. Dadban, E. Carmi

引用次数: 0

Teaching dermatology in the 21st century – The digital train has already left, but are we on it? 21世纪的皮肤病学教学——数字列车已经离开，但我们还在上面吗?

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.03.011

A. Salava, N. Kluger

引用次数: 0

Subcutaneous panniculitis-like T-cell lymphoma presenting as facial infiltration with long-term response to methotrexate: Two cases 皮下泛膜炎样t细胞淋巴瘤表现为面部浸润，甲氨蝶呤长期有效:2例

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.04.003

D. Marcé , D. Canu , C. Laurent , C. Pottier , M.-L. Jullie , T. Kervarrec , M. Beylot-Barry , M. Samimi

引用次数: 0

Omalizumab-induced paradoxical urticaria responsive to dupilumab omalizumab诱导的对dupilumab应答的矛盾荨麻疹

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.007

A.-C. Fougerousse, A. Badaoui

引用次数: 0

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer 阿扑胺治疗前列腺癌症后罕见且严重的地衣样皮肤出疹。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.001

P.-F. Guglielmini, C. Massone, C. Grasso, A. Francese, M. Vincenti, S. Chiodi, M. Rossi, A. Maconi

引用次数: 0

Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec 蕈样肉芽肿和Sézary综合征的临床特征、初步治疗和预后：魁北克大学医院中心的一项回顾性单中心研究。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.006

M. Lachance, M.-M. Thibeault

引用次数: 0

A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin 面部血管纤维瘤伴结节性硬化症患者的调查：局部雷帕霉素的短期、中期和长期疗效和安全性。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.06.009

N. Sigg , J. Fouquet , D. Morin , D. Farges , S. Vrignaud , L. Martin

{"title":"A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin","authors":"N. Sigg , J. Fouquet , D. Morin , D. Farges , S. Vrignaud , L. Martin","doi":"10.1016/j.annder.2023.06.009","DOIUrl":"10.1016/j.annder.2023.06.009","url":null,"abstract":"<div><h3>Aims</h3><p><span>Topical rapamycin<span> is used to reduce facial angiofibromas<span> in patients with </span></span></span>tuberous sclerosis (TSC). In the absence of a commercially available preparation, numerous formulations have been tested clinically, although only in the short term.</p></div><div><h3>Methods</h3><p>The pharmacy at Angers University Hospital (France) produced a cream formulation that was administered to people presenting this genetic disease. We conducted a questionnaire-based survey among 79 patients with TSC about their perceptions regarding the short-, medium- and long-term efficacy and safety of a topical rapamycin preparation in relation to facial angiofibromas.</p></div><div><h3>Results</h3><p>This formulation was very well tolerated and its efficacy was sustained over the long term with a mean treatment duration of 33 months (extremes 1–60). Efficacy was rated ≥ 8/10 by 67.1% of patients while safety was rated ≥ 8/10 by 84.8% of patients.</p></div><div><h3>Conclusion</h3><p>This survey supports the safety and efficacy of topical rapamycin in the short-, medium- and long-term in the treatment of facial angiofibromas in a cohort of 79 patients with TSC.</p></div>","PeriodicalId":7900,"journal":{"name":"Annales De Dermatologie Et De Venereologie","volume":"150 4","pages":"Pages 270-273"},"PeriodicalIF":0.9,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41188901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cutaneous pseudolymphoma following sub-cutaneous immunotherapy for dust mites 皮肤假性淋巴瘤后皮下免疫治疗尘螨。

IF 0.9 4区医学

Annales De Dermatologie Et De Venereologie Pub Date : 2023-12-01 DOI: 10.1016/j.annder.2023.09.002

A. Badaoui, I. Moulonguet

引用次数: 0